- Filed
- Apr 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 9, 2025 | 582.37K sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 62 sh |
| Capex | FY 2024 · Dec 31, 2023 | $0 |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$3.65M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $1.02M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $3.19M |
| Current Assets | FY 2024 · Dec 31, 2023 | $1.29M |
| Total Assets | FY 2024 · Dec 31, 2023 | $2.46M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$79,782.00 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$79,782.00 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $3.25M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $873.34K |
| Net Income | FY 2024 · Dec 31, 2023 | −$4.91M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$4.88M |
| Gross Profit | FY 2024 · Dec 31, 2023 | −$324 |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $75.73K |
| Revenue | FY 2024 · Dec 31, 2023 | $75.4K |